Sigma-Aldrich Corporation  

(Public, NASDAQ:SIAL)   Watch this stock  
Find more results for NYSE:SIAL
93.82
-0.92 (-0.97%)
After Hours: 93.80 -0.02 (-0.02%)
Apr 23, 5:11PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 93.74 - 94.95
52 week 76.47 - 96.87
Open 94.68
Vol / Avg. 517,062.00/545,869.00
Mkt cap 11.15B
P/E 23.12
Div/yield 0.23/0.98
EPS 4.06
Shares 118.81M
Beta 1.03
Inst. own 84%
May 6, 2014
Sigma-Aldrich Corporation Annual Shareholder Meeting - 12:00PM EDT - Add to calendar
Apr 24, 2014
Q1 2014 Sigma-Aldrich Corporation Earnings Conference Call - 11:00AM EDT - Add to calendar
Apr 24, 2014
Q1 2014 Sigma-Aldrich Corporation Earnings Release - 9:30AM EDT - Add to calendar
Mar 12, 2014
Sigma-Aldrich Corporation Annual Business Review
Feb 25, 2014
Sigma-Aldrich Corporation at Citi Global Healthcare Conference
Feb 13, 2014
Sigma-Aldrich Corporation at Leerink Swann Global Healthcare Conference
Feb 6, 2014
Q4 2013 Sigma-Aldrich Corporation Earnings Conference Call - Webcast
Feb 6, 2014
Q4 2013 Sigma-Aldrich Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 19.15% 18.16%
Operating margin 25.00% 24.45%
EBITD margin - 30.36%
Return on average assets 13.86% 12.88%
Return on average equity 18.62% 18.05%
Employees 9,000 -
CDP Score - 97 B

Address

3050 Spruce Street
ST. LOUIS, MO 63103
United States - Map
+1-314-7715765 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of chemicals, biochemicals and equipment available globally and also provides global biopharmaceutical testing services. These chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. As of December 31, 2012, the Company offered approximately 45,000 equipment products. On January 31, 2012, the Company completed its acquisition of all of interest of BioReliance, a provider of global biopharmaceutical testing services. On April 2, 2012, the Company acquired Research Organics, a supplier of purity biochemicals.

Officers and directors

Barrett A. Toan Independent Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Rakesh Sachdev President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Jan A. Bertsch Chief Financial Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Gilles A. Cottier Executive Vice President, President - SAFC Commercial
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Eric Mark Green Executive Vice President; President - Research
Age: 44
Bio & Compensation  - Reuters
Franklin D. Wicks Jr. Executive Vice President; President - Applied
Age: 60
Bio & Compensation  - Reuters
George Lloyd Miller Senior Vice President, General Counsel, Secretary
Age: 59
Bio & Compensation  - Reuters
Karen J. Miller Senior Vice President - Corporate Development and Corporate Communications
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Kanan Vice President, Corporate Controller
Age: 50
Bio & Compensation  - Reuters
Michael Hollenkamp Vice President, Treasurer
Bio & Compensation  - Reuters